Allergy To Lepidoglyphus Destructor clinical trials

Explore recruiting allergy to lepidoglyphus destructor clinical trials.

Also recruiting in Europe

Allergy To Lepidoglyphus Destructor trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Lepidoglyphus destructor extract. Determination of in vivo allergenic potency in histamine equivalent prick testing units (HEP).

Spain

Therapeutic exploratory (Phase II) EU CTIS Study details

Allergen extract of Lepidoglyphus destructor. Study of the sensitivity and specificity of the diagnostic preparation in prick tests

Spain

Therapeutic confirmatory (Phase III) EU CTIS Study details

Allergy To Lepidoglyphus Destructor trials by city

Allergy To Lepidoglyphus Destructor in Toronto Allergy To Lepidoglyphus Destructor in Vancouver Allergy To Lepidoglyphus Destructor in Montreal Allergy To Lepidoglyphus Destructor in Calgary Allergy To Lepidoglyphus Destructor in Edmonton Allergy To Lepidoglyphus Destructor in Ottawa Allergy To Lepidoglyphus Destructor in Winnipeg Allergy To Lepidoglyphus Destructor in Quebec City Allergy To Lepidoglyphus Destructor in Hamilton Allergy To Lepidoglyphus Destructor in Kitchener Allergy To Lepidoglyphus Destructor in London Allergy To Lepidoglyphus Destructor in Halifax Allergy To Lepidoglyphus Destructor in New York Allergy To Lepidoglyphus Destructor in Los Angeles Allergy To Lepidoglyphus Destructor in Chicago Allergy To Lepidoglyphus Destructor in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease